A parenteral device having a body slidably supporting a hollow needle. The needle is slidable between a first position in which it is completely retracted within the body and a second position wherein a portion of the needle projects outside of the body. The body further houses a chamber isolated from the needle when the needle is in the first position. Movement of the needle into the second position causes an end of the needle to pierce a wall of the chamber thereby establishing communication between the chamber and needle.

Patent
   5645536
Priority
Jul 04 1990
Filed
Jun 19 1995
Issued
Jul 08 1997
Expiry
Jan 11 2013
Assg.orig
Entity
Small
30
18
EXPIRED
1. A parenteral device comprising a body, the body having a chamber which is stationary relative to the body, a hollow needle having a pointed one end with a first aperture at the one end, the needle being supported in the body for slidable movement between a first position and a second position wherein said first position comprises said needle being fully accommodated in the body, said second position comprises said one end of said needle extending beyond the body, said needle having a second aperture inward of the first aperture, said needle in movement from the first position to the second position being capable of piercing the chamber and causing the second aperture to be brought into open communication with the interior of the chamber when in the second position to allow flow of fluid between the chamber and the first aperture, the needle being substantially co-linear with the body and said second aperture being spaced axially along said needle from the one end and wherein on movement of the needle from the first position to the second position, the one end of the needle successively pierces opposed sides of the chamber to pass through the chamber when bringing the second aperture into open communication with said interior.
2. A parenteral device as claimed at claim 1 wherein the needle is retained in a substantially enclosed space in the body when in the first position and the body is formed with a wall which is sealingly pierced by the one end on movement of the needle from the first position to the second position.
3. A parenteral device as claimed at claim 1 wherein a retention means is provided to retain the needle in the first position on movement of the needle from the second position to the first position, said retention means preventing subsequent movement of the needle from the first position to the second position.
4. A parenteral device as claimed at claim 1 wherein said chamber is sealed and at least a portion of the wall of the chamber is flexible.
5. A parenteral device as claimed at claim 4 wherein the portion of the wall is resiliently flexible.
6. A parenteral device as claimed at claim 5 wherein the portion of the wall is resiliently biased to a minimum volume position of the chamber.
7. A parenteral device as claimed at claim 5 wherein the portion of the wall is resiliently biased to a maximum volume position of the chamber.

This is a continuation of application Ser. No. 07/960,379, filed Jan. 11, 1993, now U.S. Pat. No. 5,425,722.

1. Field of the Invention

The invention relates to a parenteral device which may take the form of a syringe or similar parenteral device or a cannula.

2. Prior Art

In the use of syringes, cannulas and the like which utilize sharp hollow needles there has been significant awareness recently of the dangers which exist as a result of the usage and disposal of these devices. The evidence of such dangers resides in the frequency with which users of the devices are inadvertently pricked. Such an injury can result in the transmission of disease.

As a result of these difficulties users of parenteral devices such as medical clinics, hospitals and the like apply very stringent procedures in the storage, use and disposal of parenteral devices which utilize sharp needles. However, despite such very stringent procedures it is a regular occurrence for professional users to be inadvertently pricked.

In addition there is a need for the parenteral devices such as syringes to be generally available to patients for the self application of parenteral agents to those patients. This is particularly the case where patients are required to regularly administer to themselves agents which must be regularly administered and can only be administered by hypodermic or intravenous injection. As a result it is necessary for such users to have readily available to them ampoules which store the active agent, syringes and needles. When administration is required the users must assemble the syringe, fill the syringe and needles. When administration is required the users must assemble the syringe, fill the syringe with the parenteral agent, inject themselves with the agent and then dispose of the syringe and needle in a responsible manner. In addition when administration is required the user can often be experiencing stress which can make the tasks of assembling the syringe, filling the syringe, injection and disposal of the syringe a difficult exercise.

In addition as a result of the use of illegal drugs which are generally administered intravenously by utilization of syringes there has arisen considerable difficulty as a result of the inappropriate disposal of such syringes by the users of illegal drugs and increased danger of transmission of disease due to such syringes being carelessly disposed of or used by a second person.

It is an object of the invention to at least partially alleviate the difficulties that are created by the use and disposal of the conventional syringes by professionals, patients and drug users.

These and other aspects and objects are provided according to the invention in a parenteral device comprising a body, the body having a chamber which is stationary relative to the body, a hollow needle having a pointed one end with a first aperture at the one end, the needle being supported in the body for slidable movement between a first position and second position wherein said first position comprises said needle being fully accommodated in the body, said second position comprises said one end of said needle extending beyond the body, said needle having a second aperture inward of the first aperture, said needle in its movement from the first position to the second position being capable of piercing the chamber and causing the second aperture to be brought into open communication with the interior of the chamber when in the second position to allow the flow of fluid between the chamber and first aperture, the needle being substantially co-linear and said second aperture being spaced axially along said needle from the one end and where in on movement of the needle from the first position to the second position, the one end of the needle pierces opposed sides of the chamber to pass through the chamber.

According to a preferred form of the invention, the needle is retained in a substantially enclosed space in the body when in the first position and the body if formed with a wall which is sealingly pierced by the one end on movement of the needle from the first position to the second position.

In addition, a retention means may be provided to retain the needle in the first position on movement of the needle from the second position to the first position, said retention means preventing the subsequent movement of the needle from the first position to the second position.

Preferably, the retention means comprises an abutment located to be engaged by the needle on movement towards or away from the second position to cause deformation of the needle, which deformation allows movement of the needle from its second position.

A number of additional features and objects will be apparent in connection with the following discussion of preferred embodiments and examples.

There are shown in the drawings certain exemplary embodiments of the invention as presently preferred. It should be understood that the invention is not limited to the embodiments disclosed as examples, and is capable of variation within the scope of the appended claims. In the drawings,

FIG. 1 is a sectional side elevation of the first embodiment showing the needle in the first position;

FIG. 2 is a sectional side elevation of the first embodiment showing the needle in the second position;

FIG. 3 is a isometric view of the moulding which forms the body of the first embodiment;

FIG. 4 is an isometric inverted view of the moulding shown at FIG. 3 showing the handle and needle in position;

FIG. 5 is an isometric view of the embodiment with the needle in the first position;

FIG. 6 is a schematic side elevation of the second embodiment showing the needle in the first position;

FIG. 7 is a schematic sectional side elevation of the second embodiment showing the needle in the second position;

FIG. 8 is a sectional side elevation of the second embodiment showing the needle in the first position having been moved from that position to the second position;

FIG. 9 is a schematic sectional side elevation of the third embodiment;

FIG. 10 is a cross-sectional view along the line A--A of FIG. 9;

FIG. 11 is a cross-sectional view along the line B--B of FIG. 9;

FIG. 12 is a schematic view of the fourth embodiment of the invention with the needle in the second position;

FIG. 13 is a schematic sectional view of the embodiment with the needle in the first position;

FIG. 14 is a schematic elevation of the fifth embodiment of the invention with the needle in the first position;

FIG. 15 is a schematic elevation of the fifth embodiment showing the needle in the second position; and

FIGS. 16 and 17 are a schematic representation of a sixth embodiment of the invention.

The first embodiment of the invention which is shown at FIGS. 1, 2, 3, 4 and 5 comprises a device which enables the storage of parenteral medium with a means of dispensing that parenteral medium by injection when desired.

The embodiment comprises a moulding of plastics material which define a body 11 which is formed as two parts 11a and 11b. The body 11 is formed by a pressure injection moulding technique or like technique and has as shown in FIGS. 3 and 4 the two separate parts which are hingedly interconnected at their rear edges 12. In forming the parts 11a and 11b suitable retention means (not shown) are moulded into the opposing faces such that when opposing faces of the parts 11a and 11b are brought into face to face engagement the retention means are inter-engaged to lockably retain the two parts together.

One part 11a of the body is formed on one exterior face with concave depression 13 which is located towards the rear side of the one part and a recess 14 which is located towards the forward side of the housing.

In forming the housing the one part 11a of the housing also has integrally formed with it, by the moulding technique, a thin laminar member 15 which extends from the edge 16 of the one part 11a adjacent its external face. The laminar member 15 is formed as a parallel sided strip which extends from the front edge and terminates with a circular portion 18 having a central portion 19 of complementary configuration to the concave depression 13 which is provided on the one part. In assembling the body the laminar member 14 is laid over the exterior face of the one part 11a and it is welded or similarly fixed around its edges to the one part 11a to define a sealed reservoir between itself and the exterior face of the one part 11a. The sealed space comprises the volume of the concave depression 13 and the recess 14 together with the space that is defined between the laminar member 15 and the exterior face of the one part 11a. The central portion 17 of the laminar member is formed of a thickness such that it has resilient flexibility and has a conformity to the depression 13 when placed over the depression. On application of fluid pressure to the interior of the space defined between the one part 11a and the opposed face of the laminar member 15, by the introduction of the parenteral agent the space can be expanded.

The one part 11a is formed at its forward end with a tongue like portion 20 which accommodates the recess 14, has substantially parallel sides and which is overlaid by the parallel sided strip 17 of the laminar member 15. The underface of the tongue like portion is formed with a groove 21 which extends for a portion of the length of the tongue 20 but stops short of the recess 14. The lower face of the groove 21 is formed with a central narrower groove 22 which has the same length as the main groove 21. The inner face of the other part 11b of the body which is to be disposed in opposed relation to the groove 20 is formed with a recess such that a substantial portion of the upper part 11b defines a hollow space 23 on engagement with the one part 11a. A portion of the hollow space which lies opposite the tongue of the one part when the two parts are inter-engaged is slightly wider than the tongue to provide a slot shaped aperture 14 to each side of the tongue (see FIG. 5).

The tongue 20 of the one part 11a of the body supports a handle 25 which is formed with a handle portion 26 which is slidably received over the exterior face of the tongue 20 and is formed on its side with a pair of parallel webs 27 which are located to each side of the tongue 20 and are received in the slot shaped apertures 24 which are formed between the tongue 20 of the one part 11a and the hollow spaces 23 provided on the other part 11b. The parallel webs are interconnected by a support member 28 which has substantially T-shaped profile where the leg 29 of the section is received in the groove 21 provided on the underface of the one part 11a for a movement along the groove. The support provides support for a hook shaped needle 30 having a main body portion 31 which extends forwardly from the support parallel to the underface of the one part 11a of the body. The main body is formed with a first aperture 32 in its free end which comprises the one end of the needle. The hook portion 33 of the needle extends substantially parallel to the main portion 31 and is formed with a second aperture 34 in the other end of the needle. Both the one end and the other end of the needle are pointed.

The hook portion 33 of the needle 30 is slidably received within the minor groove 22 provided at the base of the groove 21 which is formed on the inner face of the one part 11a. The forwardmost end of the minor groove 22 terminates short of the recess 14 such that it is separated from the recess 14 by a thin wall. The inner face of the other part 11b towards the forward end of the space 23 provided in that part is also formed with a third groove 35 which terminates short of the front face such that a thin wall is provided between the end of the third groove 35 and the front face of the one member.

As a result of the engagement of the handle 25 over the tongue 20 the handle 25 is capable of slidable movement along the tongue 20 from a first position as shown at FIG. 1 where the support 20 is located towards the rear end of the groove 21 provided in the inner face of the one part 11a and a second position shown at FIG. 2 where it is located adjacent the front face of the groove. On movement of the handle from the first position to the second position the one end of the needle 30 pierces the thin wall provided at the front end of the third groove 35 to become exposed to the exterior of the body. The other end of the needle pierces the wall between the front end of the minor groove 21 and the recess 14 when the handle is almost at its second position. The piercing of the recess by the hook portion 33 then provides communication between the first aperture 32 at the one end of the needle and the volume defined by the chamber which was formed between the outer face of the one part 11a and the laminar member 15. As a result there is a flow of fluid from the chamber into the second aperture 34 through the needle and out of the first aperture 32 on the volume of the chamber being reduced. The reduction of the volume in the chamber can be effected by the application of pressure by the central portion 19 of the laminar member which is located above depression 13 provided in the body due to the resilient biasing caused by the expansion of the central portion when the chamber is filled. Such pressure can also be applied by a finger or a thumb.

As stated if desired the central portion 19 of the laminar member 15 may have its own resilience and be biased to a minimum volume position whereby on the second end 34 of the needle piercing the recess 14 the chamber will collapse under the resilient pressure applied by the central portion 19 to cause the injection of parenteral medium into the tissue from the one end of the needle. In such an instance the insertion of the one end of the needle into the tissue is effected while the needle is being moved from its first to its second position on the body 11. This can be effected by locating the front end of the body 11 adjacent to the skin of the patient and then moving the needle in a single action from the first position to the second position during which phase it will enter the tissue of the patient. Alternatively the central portion 19 of the laminar member 15 may have a resilience whereby it is biased to a maximum volume position which will require the application of thumb or finger pressure to effect injection of the parenteral agent into the tissue of the patient.

On completion of the injection of the parental medium the needle is then moved to its first position by rearward movement of the handle in the body. Once the needle has been safely located into its first position whereby the one end of the needle is safely accommodated within the body the device may be disposed of with little likelihood of there being any inadvertent pricking of any person who comes into contact with the device. If desired a locking means may be provided between the body and the handle which will engage the handle on it being removed rearwardly to the first position and which will positively lock the handle into its first position. Alternatively, a biasing means may be provided between the handle and the body which biases the handle to the first position whereby movement of the handle from the first to the second position requires positive movement against the biasing force and on the removal of the application force the biasing will cause the retraction of the handle and needle.

To fill the chamber between the one part 11a and the laminar member a hollow needle can be caused to pierce the one part to enter the depression 13 or recess 14 and a parenteral agent is injected into the chamber. If the body is formed of a suitable resiliently flexible plastics material the hole caused by the hollow needle can be self sealing. Alternatively the hole can be sealed by wadding or by application of a sealant or by gluing.

The embodiment provides a means of safely storing a parenteral agent in association with a needle whereby when it is required to effect injection of the parenteral medium into tissue of the patient there is no requirement for the patient to install the needle separately to the body of the syringe, nor to fill the syringe with the parenteral agent before the agent can be applied as is the conventional technique. Furthermore, prior to use and subsequent to the use the needle is stored in a position where it is not accessible for any inadvertent pricking of any user or person who may handle the syringe.

The second embodiment of the invention which is shown very schematically at FIGS. 6, 7, and 8 is directed to an application of the invention to a substantially conventional syringe. The syringe comprises a substantially hollow cylindrical body 111 having a closed end 112 which accommodates a plunger 113 having a piston 114 at its inner end which is slidably and sealingly received in the bore of the cylinder. The syringe is associated with a tubular member 115 which is fixed to the side of the cylindrical body, is substantially parallel thereto and has an opening 116 adjacent the closed end 112 of the cylindrical body. The tubular element receives a rod shaped member 117 having a handle 118 at its outer end and which supports at its inner end a hook shaped hollow needle 119. The main body 119a of the needle accommodates the pointed first end 120 of the needle which lies adjacent the opening 116 when the rod shaped member and needle are in the retracted first position in the tubular member 115. The hook shaped portion 119b of the needle provides the second end 121 of the needle which is also pointed.

The lower portion of the cylinder adjacent the closed end 112 is formed with a transversely directed portion 122 which defines an extension of the space defined by the bore of the cylinder and is formed with transverse wall 123 which extends into the tubular member to intersect across the path of the second end 121 of the needle as the needle is moved from its first position at which the main body 119a accommodated within the tubular member, to its second position as shown in FIG. 7, at which the main body 119a of the needle and the first end 120 of the needle is exposed from the body. Towards the end of such movement the second end 121 of the needle will engage the transverse wall 120 and pierce that wall such that the aperture provided in the second end of the needle comes into open communication with the interior of the chamber defined by the cylindrical body. On manipulation of the plunger parenteral fluid can be expelled from the chamber through the one end of the needle of the needle by moving the plunger into the cylindrical body.

As a result of the second end 121 of the needle piercing the transverse wall 123 it is caused to be deformed or bent outwardly. On completion of the use of the syringe the needle is then withdrawn to its first position by utilization of the handle 118 provided on the outer end of the rod member 117. However, due to the deformation of the hook portion 119a of the needle the other end of the needle is caused to be brought into engagement with the interior wall of the tubular member. As a result of the deformed orientation of the needle the hook shaped portion is able to slide rearwardly into the tubular member with the application of some additional effort to the handle 118 but the interference effected by the engagement of the second end 121 of the needle with the side wall of the tubular member prevents further movement of the needle from the first position and thus the needle is locked into the first position. Furthermore, the rod member may be formed with a line of weakness 121 whereby it can be broken along that line of weakness and prevent further utilization of the handle 18 to cause movement of the needle.

As a result of the second embodiment a syringe is provided whereby the interior of the chamber of the syringe will remain isolated until such time as the syringe is required to be used either to draw parenteral fluid into or for the injection of a parenteral agent which is stored within the chamber. The movement of the needle to its extended second position such that the syringe can be used for the injection of the parenteral agent into tissue of the body or withdrawal of a parenteral agent from the tissue of the body can be readily achieved in a simple manual function. Finally on completion of the usage of the device the needle can be retracted to a first position at which it is not accessible and the needle can be locked in that position to prevent any further inadvertent use of the syringe or inadvertent pricking of any person who may come in contact with the syringe.

The third embodiment shown at FIGS. 9, 10 and 11 is of a similar form to the second embodiment shown at FIGS. 6, 7, and 8. Accordingly, corresponding numerals have been used in relation to corresponding components between the second and third embodiments. The difference of the third embodiment from the second embodiment resides in the presence of an additional retractable 130 needle which is co-linear and is provided with a second aperture 131 in its side wall which can be brought into selective engagement with an aperture provided in the wall of the cylindrical body on the needle being moved to an extended position. The second needle 130 can be utilized for the withdrawal of a parenteral agent form an ampoule and on completion of the filing of the chamber of the syringe the second needle can be moved to a position at which the needle 119 is exposed within the body and the first hook shaped needle is brought into engagement with the chamber to allow for the injection of the parenteral medium into the body of a patient.

The fourth embodiment of FIGS. 12 and 13 comprises a cannula which is substantially similar to that of the first embodiment described in relation to FIGS. 1 to 5 except that the chamber includes a reservoir 140 which is remote from the body of the device and which is in communication with a recess 141 provided in the body 142 of the device through a tube 143. The hook portion 145 of the needle 146 can be brought into selective engagement with the recess 141. It is envisaged that the fourth embodiment would have application in the collection of fluids such as blood from the body of a patient whereby the blood collection bag incorporates the cannula of the embodiment as a unitary component and there is no need for assembly prior to its utilization.

The fifth embodiment shown at FIGS. 14 and 15 is directed to an injection device whereby the needle 160 is of a co-linear configuration and is received on one end of a rod shaped member 161 having a handle 162 at is outer end. The second aperture 163 of the needle 160 is provided along the length of the needle. As in the case of the first embodiment the chamber is defined between an external face of the body 164 and a laminar element 165 which is bonded around its sides to the external face of the body 164 which is provided with a concave depression 166 and is formed with an extension 167 which extends into the body across the path of the needle as it moves from its first position at which the needle is fully accommodated within the body to its second position at which the needle is exposed. On movement of the needle from the first position to the second position it will pierce the extension 167 and on attaining its second position the second aperture will come into communication with the interior of the chamber to allow for the expulsion of the parenteral agent from the chamber through the hollow needle.

The sixth embodiment of the invention shown at FIGS. 16 and 17 relates to a sampling device. The sixth embodiment is similar in a very general form to the second embodiment shown at FIGS. 6, 7 and 8 except that the chamber A is defined by a container 210 which has an open end closed by a cap 211. The cap 211 has a socket which will sealingly receive the open end of the container 210 and is formed with a tubular sub housing 215. The sub housing 215 accommodates a needle body having a rod-shaped member 217 with a handle 218 at its outer end, which supports a hook shaped needle 219 at its other end. As in the second embodiment of FIGS. 6, 7 and 8 the hooked needle is slidably movable between a first position shown at FIG. 17 at which the one end 220 of the needle is within the tubular sub housing 215 and a second position shown at FIG. 16 at which the needle extends from the tubular body 215. The cap 211 is formed with a transverse wall 223 which is pierced by the other end 221 of the hooked needle as it approaches the second position to provide communication between the chamber A and the one end 210 of the needle.

In use the chamber A is evacuated and if the one end of the needle is caused to enter the body of a patient just prior to the needle being moved fully into the second position body fluids will be drawn into the chamber on the needle being moved fully to the second position.

The invention having been disclosed in connection with the foregoing variations and examples, additional variations will now be apparent to persons skilled in the art. The invention is not intended to be limited to the variations specifically mentioned, and accordingly reference should be made to the appended claims rather than the foregoing discussion of preferred examples, to assess the scope of the invention in which exclusive rights are claimed.

Whisson, Maxwell Edmund

Patent Priority Assignee Title
10709849, Jun 11 2013 Cilag GmbH International Guide for an injection device
10799646, Jun 11 2013 Cilag GmbH International Injection device
11123492, Jun 11 2013 Cilag GmbH International Injection device
11173255, Jun 11 2013 Cilag GmbH International Injection device
5957895, Feb 20 1998 Becton, Dickinson and Company Low-profile automatic injection device with self-emptying reservoir
6454746, Jun 04 1997 Eli Lilly and Company Medication delivery apparatus
6848598, Sep 04 2000 Genosis Limited Fluid dispensing apparatus
8277414, May 28 2004 Cilag GmbH International Injection device
8313463, May 28 2004 Cilag GmbH International Injection device
8313464, May 28 2004 Cilag GmbH International Injection device
8313465, May 28 2004 Cilag GmbH International Injection device
8317751, Apr 06 2005 Cilag GmbH International Injection device
8343110, May 28 2004 Cilag GmbH International Injection device
8366669, Apr 06 2005 Cilag GmbH International Injection device
8834419, Jun 19 2008 Cilag GmbH International Reusable auto-injector
8845594, Jun 19 2008 Cilag GmbH International Auto-injector with filling means
8939958, Jun 19 2008 Cilag GmbH International Fluid transfer assembly for a syringe
8968236, Apr 06 2005 Cilag GmbH International Injection device
9028451, Jun 01 2006 Cilag GmbH International Injection device
9028453, Jun 19 2008 Cilag GmbH International Reusable auto-injector
9072833, Jun 01 2006 Cilag GmbH International Injection device
9358346, Aug 31 2012 Cilag GmbH International Needle assembly for a prefilled syringe system
9649441, Apr 06 2005 Cilag GmbH International Injection device (bayonet cap removal)
9675757, May 28 2004 Cilag GmbH International Injection device
9675758, May 28 2004 Cilag GmbH International Injection device
9682194, Jun 19 2008 Cilag GmbH International Re-useable auto-injector with filling means
9731080, Apr 06 2005 Cilag GmbH International Injection device
9757520, Jun 01 2006 Cilag GmbH International Injection device
9770558, Sep 27 2005 Cilag GmbH International Auto-injection device with needle protecting cap having outer and inner sleeves
9895493, May 28 2004 Cilag GmbH International Injection device
Patent Priority Assignee Title
3306290,
3563373,
4728320, Apr 17 1987 Syringe cap with hammer
4747831, Apr 29 1987 PHASE MEDICAL, INC , 523 WEST SIXTH STREET, SUITE 737, LOS ANGELES, CA 90014 A CORP OF CA Cannula insertion set with safety retracting needle
4767413, Apr 20 1987 Habley Medical Technology Corporation Dental syringe having an automatically retractable needle
4813426, Nov 09 1987 HABLEY MEDICAL TECHNOLOGY CORPORATION, 22982 ALCALDE, LAGUNA HILLS, CA 92653, A CA CORP Shielded safety syringe having a retractable needle
4850961, Jul 30 1987 Indwelling placement device with guard
4900310, Oct 07 1988 International Medication Systems, Limited Protective device for cannula used to draw blood
4994042, Oct 02 1989 Combined catheter and needle
5061249, Mar 16 1990 Hypodermic injection device
5248303, Aug 27 1991 Medical syringe with needle-retracting mechanism
5498245, Nov 20 1991 Eastland Technology Australia Pty Ltd Attachment for a parenteral device
5569192, Mar 27 1992 Duphar International Research B.V. Automatic injector
EP388169,
FR2240025,
WO8808315,
WO8904141,
WO9007349,
//
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 19 1995Eastland Technology Australia Pty Ltd.(assignment on the face of the patent)
Mar 05 1997WHISSON, MAXWELL EDMUNDEastland Technology Australia Pty LtdASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0086780108 pdf
Date Maintenance Fee Events
Jan 03 2001M283: Payment of Maintenance Fee, 4th Yr, Small Entity.
Dec 20 2004M2552: Payment of Maintenance Fee, 8th Yr, Small Entity.
Jan 13 2009REM: Maintenance Fee Reminder Mailed.
Jul 08 2009EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jul 08 20004 years fee payment window open
Jan 08 20016 months grace period start (w surcharge)
Jul 08 2001patent expiry (for year 4)
Jul 08 20032 years to revive unintentionally abandoned end. (for year 4)
Jul 08 20048 years fee payment window open
Jan 08 20056 months grace period start (w surcharge)
Jul 08 2005patent expiry (for year 8)
Jul 08 20072 years to revive unintentionally abandoned end. (for year 8)
Jul 08 200812 years fee payment window open
Jan 08 20096 months grace period start (w surcharge)
Jul 08 2009patent expiry (for year 12)
Jul 08 20112 years to revive unintentionally abandoned end. (for year 12)